Rachel M Williamson
Overview
    Explore the profile of Rachel M Williamson including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              18
            
            
              Citations
              400
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Grecian S, McLachlan S, Fallowfield J, Hayes P, Guha I, Morling J, et al.
  
  
    Obes Sci Pract
    . 2021 Oct;
          7(5):497-508.
    
    PMID: 34631129
  
  
          Background: Type 2 diabetes (T2D) is associated with increased risk of progression to cirrhosis and hepatocellular carcinoma (HCC) in people with chronic liver diseases, particularly non-alcoholic fatty liver disease (NAFLD)....
      
2.
        
    
    Grecian S, McLachlan S, Fallowfield J, Kearns P, Hayes P, Guha N, et al.
  
  
    Liver Int
    . 2020 Jul;
          40(9):2252-2262.
    
    PMID: 32638496
  
  
          Background: The incidence of cirrhosis and hepatocellular carcinoma (HCC) is increased in Type 2 diabetes, primarily secondary to non-alcoholic fatty liver disease (NAFLD). European guidelines recommend screening for NAFLD in...
      
3.
        
    
    Jenks S, Conway B, McLachlan S, Teoh W, Williamson R, Webb D, et al.
  
  
    Diabetologia
    . 2017 May;
          60(8):1400-1408.
    
    PMID: 28528401
  
  
          Aims/hypothesis: We investigated whether biochemical cardiovascular risk factors and/or markers of subclinical cardiovascular disease were associated with the development of reduced renal function in people with type 2 diabetes. Methods:...
      
4.
        
    
    Morling J, Fallowfield J, Williamson R, Robertson C, Glancy S, Guha I, et al.
  
  
    Diabetologia
    . 2015 Mar;
          58(7):1484-93.
    
    PMID: 25820150
  
  
          Aims/hypothesis: We examined the association of prevalent and incident cardiovascular disease (CVD) with chronic liver disease in a cohort of community-based people with type 2 diabetes, in order to clarify...
      
5.
        
    
    Sun K, Xiao Z, Lu S, Zajaczkowski W, Pisula W, Hanssen E, et al.
  
  
    Nat Commun
    . 2015 Jan;
          6:6013.
    
    PMID: 25586307
  
  
          Solution-processed organic photovoltaic cells (OPVs) hold great promise to enable roll-to-roll printing of environmentally friendly, mechanically flexible and cost-effective photovoltaic devices. Nevertheless, many high-performing systems show best power conversion efficiencies...
      
6.
        
    
    Morling J, Fallowfield J, Guha I, Nee L, Glancy S, Williamson R, et al.
  
  
    J Hepatol
    . 2014 Feb;
          60(2):384-91.
    
    PMID: 24512822
  
  
          Background & Aims: It is difficult to determine the different stages of non-alcoholic fatty liver disease without the use of invasive liver biopsy. In this study we investigated five non-invasive...
      
7.
        
    
    Morling J, Fallowfield J, Williamson R, Nee L, Jackson A, Glancy S, et al.
  
  
    Liver Int
    . 2013 Nov;
          34(8):1267-77.
    
    PMID: 24237940
  
  
          Background & Aims: Type 2 diabetes is an established risk factor for the presence and progression of fatty liver. Little is known about the distributions and correlates of hepatic non-invasive...
      
8.
        
    
    Anderssohn M, McLachlan S, Luneburg N, Robertson C, Schwedhelm E, Williamson R, et al.
  
  
    Diabetes Care
    . 2013 Nov;
          37(3):846-54.
    
    PMID: 24186881
  
  
          Objective: To investigate determinants of asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA), including single nucleotide polymorphisms (SNPs), in the DDAH1, DDAH2, and AGXT2 genes and their associations with prevalent and...
      
9.
        
    
    Feinkohl I, Keller M, Robertson C, Morling J, Williamson R, Nee L, et al.
  
  
    Diabetes Care
    . 2013 Apr;
          36(9):2779-86.
    
    PMID: 23579182
  
  
          Objective: Macrovascular disease may contribute to increased risk of accelerated cognitive decline in patients with type 2 diabetes. We aimed to determine associations of measures of macrovascular disease with cognitive...
      
10.
        
    
    Teoh W, Price J, Williamson R, Payne R, Van Look L, Reynolds R, et al.
  
  
    J Hypertens
    . 2013 Mar;
          31(5):1010-7.
    
    PMID: 23492645
  
  
          Objective: Increased arterial stiffness, as measured by pulse wave velocity (PWV), is associated with increased cardiovascular risk in the general population. Few studies have examined factors associated with increased PWV...